Arcadia Biosciences, Inc. (RKDA)
USD 5.87
(-0.51%)
USD 5.87
(-0.51%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -13.93 Million USD | 28.54% |
| 2022 | -19.4 Million USD | 45.38% |
| 2021 | -35.52 Million USD | -64.53% |
| 2020 | -21.59 Million USD | -5.94% |
| 2019 | -20.38 Million USD | -20.81% |
| 2018 | -16.87 Million USD | -17.85% |
| 2017 | -14.31 Million USD | 23.12% |
| 2016 | -18.62 Million USD | -19.64% |
| 2015 | -15.56 Million USD | -2.71% |
| 2014 | -15.15 Million USD | -43.41% |
| 2013 | -10.56 Million USD | -4.3% |
| 2012 | -10.13 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -3.02 Million USD | 7.04% |
| 2024 Q2 | -2.02 Million USD | 165.43% |
| 2023 Q3 | -3.24 Million USD | 14.48% |
| 2023 Q2 | -3.79 Million USD | 6.35% |
| 2023 FY | -13.86 Million USD | 28.54% |
| 2023 Q1 | -4.04 Million USD | 30.57% |
| 2023 Q4 | -3.25 Million USD | -0.4% |
| 2022 Q1 | -4.62 Million USD | 66.51% |
| 2022 Q2 | -4.6 Million USD | 0.5% |
| 2022 Q3 | -4.55 Million USD | 0.96% |
| 2022 FY | -19.4 Million USD | 45.38% |
| 2022 Q4 | -5.83 Million USD | -27.96% |
| 2021 Q3 | -8.71 Million USD | -13.42% |
| 2021 Q1 | -5.32 Million USD | -171.31% |
| 2021 FY | -35.52 Million USD | -64.53% |
| 2021 Q4 | -13.8 Million USD | -58.43% |
| 2021 Q2 | -7.68 Million USD | -44.24% |
| 2020 Q2 | -6.87 Million USD | -18.76% |
| 2020 FY | -21.59 Million USD | -5.94% |
| 2020 Q4 | 7.46 Million USD | 198.52% |
| 2020 Q3 | -7.58 Million USD | -10.25% |
| 2020 Q1 | -5.79 Million USD | -45.15% |
| 2019 FY | -20.38 Million USD | -20.81% |
| 2019 Q3 | -6.19 Million USD | -24.33% |
| 2019 Q4 | -3.98 Million USD | 35.59% |
| 2019 Q1 | -4.21 Million USD | 3.12% |
| 2019 Q2 | -4.98 Million USD | -18.09% |
| 2018 Q1 | -3.83 Million USD | -27.97% |
| 2018 FY | -16.87 Million USD | -17.85% |
| 2018 Q4 | -4.35 Million USD | -6.22% |
| 2018 Q2 | -4.57 Million USD | -19.25% |
| 2018 Q3 | -4.09 Million USD | 10.46% |
| 2017 FY | -14.31 Million USD | 23.12% |
| 2017 Q1 | -3.96 Million USD | 27.56% |
| 2017 Q2 | -3.73 Million USD | 5.7% |
| 2017 Q3 | -3.61 Million USD | 3.26% |
| 2017 Q4 | -3 Million USD | 17.01% |
| 2016 Q1 | -4.93 Million USD | -21.2% |
| 2016 FY | -18.62 Million USD | -19.64% |
| 2016 Q4 | -5.47 Million USD | -39.32% |
| 2016 Q3 | -3.92 Million USD | 8.44% |
| 2016 Q2 | -4.28 Million USD | 13.05% |
| 2015 FY | -15.56 Million USD | -2.71% |
| 2015 Q3 | -4.23 Million USD | -19.4% |
| 2015 Q2 | -3.54 Million USD | 4.42% |
| 2015 Q1 | -3.71 Million USD | -127.67% |
| 2015 Q4 | -4.07 Million USD | 3.9% |
| 2014 Q1 | -2.58 Million USD | -13.9% |
| 2014 Q2 | -4.99 Million USD | -93.61% |
| 2014 Q3 | -5.94 Million USD | -18.88% |
| 2014 FY | -15.15 Million USD | -43.41% |
| 2014 Q4 | -1.63 Million USD | 72.57% |
| 2013 FY | -10.56 Million USD | -4.3% |
| 2013 Q4 | -2.26 Million USD | 14.29% |
| 2013 Q3 | -2.64 Million USD | 6.44% |
| 2013 Q1 | -2.82 Million USD | 0.0% |
| 2013 Q2 | -2.82 Million USD | 0.0% |
| 2012 FY | -10.13 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 44.82 Million USD | 131.097% |
| Muliang Viagoo Technology, Inc. | 467.3 Thousand USD | 3082.66% |
| N2OFF, Inc. | -7.57 Million USD | -83.933% |
| Yield10 Bioscience, Inc. | -14.41 Million USD | 3.322% |